Rotigotine

ATC N04BC09 · 9 markets · 108 records

Rotigotine 9 markets · 108 records Forms

GB 48 records · 6 strengths

ES 12 records · 12 strengths

AU 11 records · 11 strengths

  • 8 mgtopicalNeupro also in GB
  • 6 mgtopicalNeupro also in GB
  • 4 mgtopicalNeupro also in GB
  • 2 mgtopicalNeupro also in GB
  • 18 mgunknownNEUPRO rotigotine 2 mg/24 hr transdermal patch sachet unknown
  • 13.5 mgunknownNEUPRO rotigotine 2 mg/24 hr transdermal patch sachet unknown
  • 9 mgunknownNEUPRO rotigotine 2 mg/24 hr transdermal patch sachet unknown
  • 6.75 mgunknownNEUPRO rotigotine 2 mg/24 hr transdermal patch sachet unknown
  • 4.5 mgunknownNEUPRO rotigotine 2 mg/24 hr transdermal patch sachet unknown
  • 2.25 mgunknownNEUPRO rotigotine 2 mg/24 hr transdermal patch sachet unknown

Records without a stated strength · 1 Neupro

US 6 records · 6 strengths

  • 8 mg/24 htopical · extended-releaseNeupro
  • 6 mg/24 htopical · extended-releaseNeupro
  • 4 mg/24 htopical · extended-releaseNeupro
  • 3 mg/24 htopical · extended-releaseNeupro
  • 2 mg/24 htopical · extended-releaseNeupro
  • 1 mg/24 htopical · extended-releaseNeupro

CA 6 records · 6 strengths

TW 4 records · 4 strengths

HK 4 records · 1 strengths

    Records without a stated strength · 1 Neupro Transdermal Patch 2mg/24h

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Neupro

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.